FBL and rheumatoid arthritis: While no ACa-Fib IgG antibodies were measured in the healthy population, our ELISA test revealed that patients classified as having RA and OR in the VErA cohort were ACa-Fib IgG-positive in a proportion of 29.3% and 8.2% respectively.